Tumor suppressive role of the antimicrobial lectin REG3A targeting the O-GlcNAc glycosylation pathway
Authors:
- Nicolas MoniauxNMNicolas Moniaux
- Nicolas GeoffreNGNicolas Geoffre
- Alice DeshayesADAlice Deshayes
- Alexandre Dos SantosASAlexandre Dos Santos
- Sylvie JobSJSylvie Job
- Claire LacosteCLClaire Lacoste
- Tung-Son NguyenTNTung-Son Nguyen
- Marion DarnaudMDMarion Darnaud
- Mélanie Friedel-ArboleasMFMélanie Friedel-Arboleas
- Catherine GuettierCGCatherine Guettier
- Janne PurhonenJPJanne Purhonen
- Jukka KallijärviJKJukka Kallijärvi
Open Access
- 2 July 2024
- journal article
- research article
- Published by Wolters Kluwer Health in Hepatology
- Vol. 81 (5) , 1416-1432
Abstract
Background and Aims: Antimicrobial proteins of the regenerating family member 3 alpha (REG3A) family provide a first line of protection against infections and transformed cells. Their expression is inducible by inflammation, which makes their role in cancer biology less clear since an immune-inflammatory context may preexist or coexist with cancer, as occurs in HCC. The aim of this study is to clarify the role of REG3A in liver carcinogenesis and to determine whether its carbohydrate-binding functions are involved. Approach and Results: This study provides evidence for a suppressive role of REG3A in HCC by reducing O-GlcNAcylation in 2 mouse models of HCC, in vitro cell studies, and clinical samples. REG3A expression in hepatocytes significantly reduced global O-GlcNAcylation and O-GlcNAcylation of c-MYC in preneoplastic and tumor livers and markedly inhibited HCC development in REG3A-c-MYC double transgenic mice and mice exposed to diethylnitrosamine. REG3A modified O-GlcNAcylation without altering the expression or activity of O-linked N-acetylglucosaminyltransferase, O-linked N-acetylglucosaminyl hydrolase, or glutamine fructose-6-phosphate amidotransferase. Reduced O-GlcNAcylation was consistent with decreased levels of UDP-GlcNAc in precancerous and cancerous livers. This effect was linked to the ability of REG3A to bind glucose and glucose-6 phosphate, suggested by a REG3A mutant unable to bind glucose and glucose-6 phosphate and alter O-GlcNAcylation. Importantly, patients with cirrhosis with high hepatic REG3A expression had lower levels of O-GlcNAcylation and longer cancer-free survival than REG3A-negative cirrhotic livers. Conclusions: REG3A helps fight liver cancer by reducing O-GlcNAcylation. This study suggests a new paradigm for the regulation of O-GlcNAc signaling in cancer-related pathways through interactions with the carbohydrate-binding function of REG3A.Keywords
This publication has 65 references indexed in Scilit:
- The O-GlcNAcylation and its promotion to hepatocellular carcinomaBiochimica et Biophysica Acta (BBA) - Reviews on Cancer, 2022
- FOXA2 inhibits doxorubicin-induced apoptosis via transcriptionally activating HBP rate-limiting enzyme GFPT1 in HCC cellsJournal of Physiology and Biochemistry, 2021
- A Conserved Splicing Silencer Dynamically Regulates O-GlcNAc Transferase Intron Retention and O-GlcNAc HomeostasisCell Reports, 2017
- Regulation of OGT by URI in Response to Glucose Confers c-MYC-Dependent Survival MechanismsCancer Cell, 2016
- REG3A accelerates pancreatic cancer cell growth under IL-6-associated inflammatory condition: Involvement of a REG3A–JAK2/STAT3 positive feedback loopCancer Letters, 2015
- HIP/PAP prevents excitotoxic neuronal death and promotes plasticityAnnals of Clinical and Translational Neurology, 2014
- O-GlcNAcylation plays a role in tumor recurrence of hepatocellular carcinoma following liver transplantationMedical Oncology, 2011
- Human hepatocarcinoma-intestine-pancreas/pancreatitis-associated protein cures fas-induced acute liver failure in mice by attenuating free-radical damage in injured liversHepatology, 2010
- Transcriptome classification of HCC is related to gene alterations and to new therapeutic targetsHepatology, 2006
- Molecular cloning, expression and chromosomal localization of a novel human REG family gene, REG IIIGene, 2004